India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
The competition received over 42 entries from nursing colleges across Maharashtra
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Advanced image-free robotic platform to support greater precision, personalised planning, and improved patient outcomes
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Academia-industry partnership to promote indigenous technology commercialization in biotech sector
India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 3 to 6 against recommending camizestrant in combination with a CDK4/6 inhibitor
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
